Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications
1 other identifier
interventional
200
1 country
1
Brief Summary
The goal of this clinical trial is to compare two different types of perioperative mechanical ventilation (MV), specifically Protective Mechanical Ventilation (PMV) and MV with the lowest possible Driving Pressure (ΔP), in relation to the appearance of postoperative pulmonary complications (PPCs) in adult patients who are operated and have higher risk of PPCs. The main questions it aims to answer are:
- Is MV with lower ΔP better than conventional PMV in preventing PPCs in patients with higher risk for PPCs?
- Does MV with lower ΔP decrease hospital stay, Intensive Care Unit (ICU) need and mortality?
- Does MV with lower ΔP suit better than PMV to lung characteristics and needs intraoperatively? Researchers will compare MV with the lowest possible Driving Pressure (ΔP) to Protective Mechanical Ventilation (PMV) to see if any of this is more protective than the other concerning PPCs. All participants will receive perioperative MV. Half of them will receive conventional Protective Mechanical Ventilation (PMV). This will include well known generally protective settings for mechanical ventilation of patients, concerning volumes, pressures, respiratory rate, inspiratory gases and ventilation maneuvers. The rest of participants will be ventilated with the lowest possible Driving Pressure (ΔP). This will be similar to PMV in the chosen volumes, respiratory rate, inspiratory gases and ventilation maneuvers. However, the pressure inside lung at the end of expiration, eg Positive End Expiratory Pressure (PEEP), will be not be preset for every patient. Initially, the investigators will perform a maneuver that will quantify each individual's lung characteristics and mechanics. According to this, the investigators will find the exact PEEP that seems to suit each patients lungs most, and use this perioperatively, trying to provide lungs the best conditions every time. After the completion of the operation, all the patients will be screened for PPCs, via arterial blood testing and chest X ray, and the results will be statistically analyzed trying to find if any of the forementioned strategies of mechanical ventilation surpasses the other concerning PPCs appearance. PPCs include atelectasis, respiratory failure, bronchospasm, pleural effusion, pneumonia, aspiration and pneumothorax. Furthermore hospital stay, ICU need and mortality will be noted. Finally, measurements of perioperative lung pressures, volumes and derived variables will be noted and compared statistically as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2025
CompletedFirst Posted
Study publicly available on registry
September 22, 2025
CompletedStudy Start
First participant enrolled
November 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
February 11, 2026
February 1, 2026
1.8 years
August 20, 2025
February 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pulmonary Complications
Number of the following Postoperative Pulmonary Complications 1. Postoperative Atelectasis (based on Chest X-Ray in Post-Anesthesia Care Unit - PACU) 2. Postoperative Respiratory Failure based on Arterial Blood Gases in PACU (type I and/or II) 3. Postoperative Bronchospasm 4. Postoperative Pleural Effusion 5. Postoperative Pneumonia 6. Postoperative Aspiration Pneumonitis 7. Postoperative Postoperative Pneumothorax
Atelectasis -> Within 1 hour in PACURespiratory failure -> Immediately postoperatively & after 30 minutes in PACU.Bronchospasm, Pleural Effusion, Pneumonia, Aspiration Pneumonitis, Pneumothorax -> from immediately postoperative until end of study
Secondary Outcomes (8)
Hospital Stay
From day of operation until the end of patient stay inside hospital, because of return to home or due to death.
ICU need.
From day of operation until the end of patient stay inside hospital, because of return to home or due to death.
ICU stay
From day of operation until the end of patient stay inside hospital, because of return to home or due to death.
28 Day mortality
From day of operation until up to 28 days.
Mechanical Power (MP)
From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation
- +3 more secondary outcomes
Study Arms (2)
Lung Protective Ventilation
OTHERCONVENTIONAL LUNG PROTECTIVE VENTILATION This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP 8 cm H20 Tidal Volume (VT) 8 ml/kg Ideal Body Weight (IBW) Respiratory Rate (RR) --\> Arterial Partial CO2 Pressure (PaCO2) = 35-45 mmHg Inspired Oxygen Fracture (FiO2) 0.4 - 0.5 --\> Peripheral Oxygen Saturation (SpO2) \> 93% Recruitment Maneuver (as described) every hour
Minimum Driving Pressure
ACTIVE COMPARATORThis group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP; Initially 8 cm H2. Titrated at level with Minimum Driving Pressure after first recruitment - titration maneuver followed by new recruitment maneuver VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour
Interventions
This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP Initially 8 cm H2O. Afterwards, the lungs are recruited with the aforementioned maneuver. During subsequent derecruitment, PEEP is decreased by 2 cm H20 and compliance is noted in each stage. The goal is to find PEEP with maximum compliance (Cmax). A new recruitment maneuver follows and during derecruitment PEEP is set at the optimum value that was previously defined. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour
This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP 8 cm H2O. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuvers (as described) every hour
Eligibility Criteria
You may qualify if:
- \>17 years old
- Surgery with general anesthesia \& invasive mechanical ventilation
- Preoperative ARISCAT score estimation \>25
You may not qualify if:
- \<18 years old
- Preoperative ARISCAT score estimation \<26
- Women during pregnancy or just given birth
- Other type of anesthesia (Not general)
- Contraindication of administration of neuromuscular blockade agents.
- Contraindication of cease of spontaneous ventilation.
- Mechanical ventilation without endotracheal intubation.
- Severe heart failure / Severe cardiac arrhythmia.
- Severe emphysematous lung disease.
- Patient denial of participation in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Patras
Pátrai, 26504, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Diamanto Aretha, A. Professor
University of Patras
- PRINCIPAL INVESTIGATOR
Antonios Kostouros, Resident
University of Patras
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinsipal Investigator, Antonios Kostouros
Study Record Dates
First Submitted
August 20, 2025
First Posted
September 22, 2025
Study Start
November 3, 2025
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
February 11, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Beginning at the end of data collection, possibly August 2027. Ending 3 years after publication of results.
- Access Criteria
- Reviewers. Researchers of relevant subjects. Anesthesiologists with interest in optimum mechanical ventilation. A request via email will be initially needed. A data sharing agreement will be needed to be signed.
Excel file per patient containing all the collected data Preoperatively; Patient demographics, ARISCAT score Perioperatively; Mechanical ventilation settings and measurements. Type and duration of operation. Anesthetic methods. Aerial blood gases results. Data from haemodynamic monitoring. Quantity of crystalloids , vasoperessors and inotropes. Postoperatively; Arterial blood gases results in PACU, Potential presence of other postoperative pulmonary complications. Statistic analysis of the collected data